ARTICLE | Clinical News
ACAM-CDIFF regulatory update
November 8, 2010 8:00 AM UTC
sanofi-aventis disclosed in its 3Q10 earnings that FDA granted Fast Track designation for its ACAM-CDIFF vaccine against Clostridium difficile infection. The vaccine is in Phase IIb testing for the in...